Atrial Fibrillation, Persistent
48
13
18
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
1 terminated out of 48 trials
91.7%
+5.2% vs benchmark
2%
1 trials in Phase 3/4
27%
3 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (48)
Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation
Cognitive Function in Patients With Persisted Atrial Fibrillation
Hybrid Ablation of Atrial Fibrillation in Heart Failure
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success
Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
Comparison Between Extended Cryoablation, Standard Cryoablation, and Radiofrequency Ablation
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
Triple Atria Extrastimuli vs Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
Re-ablation of Persistent Atrial Fibrillation
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
Cyroablation for Pulmonary Vein Isolation Alone in Patients with Early Persistent AF Assessed by Continuous Monitoring
Optimal Pacing Rate for Cardiac Resynchronization Therapy
Comparison of Catheter Plus Marshall Vein Ablation vs. Catheter Ablation Alone in Persistent AF With Heart Failure